Stelara (Ustekinumab) for the Treatment of Moderate to Severe Crohn ’s Disease

Developed by Janssen Biotech, Stelara (Ustekinumab) is indicated for the treatment of moderate to severely active Crohn's disease.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news